Yuan, M.; Shong, K.; Li, X.; Ashraf, S.; Shi, M.; Kim, W.; Nielsen, J.; Turkez, H.; Shoaie, S.; Uhlen, M.;
et al. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma. Cancers 2022, 14, 1573.
https://doi.org/10.3390/cancers14061573
AMA Style
Yuan M, Shong K, Li X, Ashraf S, Shi M, Kim W, Nielsen J, Turkez H, Shoaie S, Uhlen M,
et al. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma. Cancers. 2022; 14(6):1573.
https://doi.org/10.3390/cancers14061573
Chicago/Turabian Style
Yuan, Meng, Koeun Shong, Xiangyu Li, Sajda Ashraf, Mengnan Shi, Woonghee Kim, Jens Nielsen, Hasan Turkez, Saeed Shoaie, Mathias Uhlen,
and et al. 2022. "A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma" Cancers 14, no. 6: 1573.
https://doi.org/10.3390/cancers14061573
APA Style
Yuan, M., Shong, K., Li, X., Ashraf, S., Shi, M., Kim, W., Nielsen, J., Turkez, H., Shoaie, S., Uhlen, M., Zhang, C., & Mardinoglu, A.
(2022). A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma. Cancers, 14(6), 1573.
https://doi.org/10.3390/cancers14061573